Waters Corporation (WAT) stock analysis
Healthcare · Diagnostics & Research
From the 10-K filed 2026-02-23
How it makes money
It generates 59% of revenue from pharmaceutical accounts, relying on recurring sales of application-specific testing kits and proprietary chromatography columns.
While it sells complex liquid chromatography and mass spectrometry hardware, recurring revenue from precision chemistry consumables and services is the primary profit driver. In 2025, chemistry sales grew 12% due to increased uptake of columns by pharmaceutical customers.
Service contracts provide a steady layer of income, representing over 35% of sales for the Waters segment in 2025. These are typically multi-year support plans for instrument maintenance and repair.
What protects it: the moat
It controls the production of specialized silica resins and uses proprietary software to lock ACQUITY UPLC hardware to its own branded columns.
It is one of only a few global suppliers that vertically integrates the manufacturing of silica and polymeric resins, column packing, and distribution. This control ensures the consistency required by highly regulated quality control laboratories.
The ACQUITY UPLC systems are designed as a closed ecosystem where the hardware and columns are mutually dependent, creating a barrier against third-party consumable replacements.
About Waters Corporation
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.